<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02386033</url>
  </required_header>
  <id_info>
    <org_study_id>GDCRI/ACM/PG/PhD/2/2013-2014AB</org_study_id>
    <nct_id>NCT02386033</nct_id>
  </id_info>
  <brief_title>Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects</brief_title>
  <official_title>Clinical Efficacy of Subgingivally Delivered Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects: A Randomized Controlled Clinical Trial .</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Dental College and Research Institute, Bangalore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Government Dental College and Research Institute, Bangalore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ABSTARCT Background: Atorvastatin is an inhibitor of 3-hydroxy-2-methyl-glutaryl coenzyme A&#xD;
      reductase. Lately, it has shown to have anti-inflammatory and bone stimulatory effects. The&#xD;
      aim of the current study is to explore the effectiveness of 1.2% atorvastatin (ATV) as an&#xD;
      adjunct to scaling and root planning (SRP) in the treatment of mandibular degree II furcation&#xD;
      defects.&#xD;
&#xD;
      Method: A total of sixty subjects were randomly assigned to two treatment groups. 1. SRP plus&#xD;
      placebo gel 2. SRP plus 1.2% ATV gel. Clinical parameters like probing depth (PD), relative&#xD;
      vertical clinical attachment level (RVCAL) , relative horizontal clinical attachment level&#xD;
      (RHCAL), modified sulcus bleeding index (mSBI) and site specific plaque index were recorded&#xD;
      at baseline and then at 3, 6 and 9 months. The radiological assessment of bone defect fill&#xD;
      was done at 6 and 9 months, using a computer-aided software.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two groups were made. One was delivered with ATV after SRP, the other was delivered with&#xD;
      placebo gel after SRP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of bone fill</measure>
    <time_frame>baseline to 9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in Relative vertical clinical attachment level</measure>
    <time_frame>baseline to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in RHCAL (relative horizontal clinical attachment level)</measure>
    <time_frame>baseline to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in probing depth</measure>
    <time_frame>baseline to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in site specific plaque index</measure>
    <time_frame>baseline to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in modified sulcus bleeding index</measure>
    <time_frame>baseline to 9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>SRP plus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>SRP was done for all the subjects. Placebo gel was delivered subgingivally into the pocket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SRP plus Atorvastatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP was done for all the subjects. Atorvastatin was delivered in the pocket subgingivally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin (ATV)</intervention_name>
    <description>After SRP, ATV gel was delivered subgingivally into the pocket</description>
    <arm_group_label>SRP plus Atorvastatin</arm_group_label>
    <other_name>ATV gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Gel</intervention_name>
    <description>After SRP, placebo gel was delivered subgingivally into the pocket</description>
    <arm_group_label>SRP plus placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  lower first molars demonstrating a probing pocket depth of 5 mm and horizontal probing&#xD;
             depth of 3 mm following phase 1 therapy, with furcation defects (degree II) present&#xD;
             bucally in asymptomatic, vital lower first molars, with a furcation radiolucency on a&#xD;
             periapical radiograph of the molars.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with systemic diseases like cardiovascular disease&#xD;
&#xD;
          -  diabetes or HIV infection or on medications like corticosteroids which may impede the&#xD;
             healing in periodontal tissues.&#xD;
&#xD;
          -  pregnant/lactating females&#xD;
&#xD;
          -  tobacco users&#xD;
&#xD;
          -  alcoholics&#xD;
&#xD;
          -  patients with unsatisfactory oral hygiene (plaque index greater than 1.5)&#xD;
&#xD;
          -  teeth having gingival recession, caries involving pulp, intrabony defect present&#xD;
             interproximally, grade 2/3 mobility&#xD;
&#xD;
          -  Furthermore, patients allergic to ATV or other statins or those taking ATV/other&#xD;
             statins systemically were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>November 30, 2014</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Dental College and Research Institute, Bangalore</investigator_affiliation>
    <investigator_full_name>Dr. A R Pradeep</investigator_full_name>
    <investigator_title>Professor and head, department of periodontics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Furcation Defects</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

